14.26
Precedente Chiudi:
$15.53
Aprire:
$15.52
Volume 24 ore:
2.07M
Relative Volume:
2.73
Capitalizzazione di mercato:
$1.50B
Reddito:
-
Utile/perdita netta:
$-150.70M
Rapporto P/E:
-9.20
EPS:
-1.55
Flusso di cassa netto:
$-125.67M
1 W Prestazione:
+0.14%
1M Prestazione:
+3.33%
6M Prestazione:
-42.01%
1 anno Prestazione:
-51.66%
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Nome
Edgewise Therapeutics Inc
Settore
Industria
Telefono
720-262-7002
Indirizzo
1715 38TH ST, BOULDER
Confronta EWTX con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
EWTX
Edgewise Therapeutics Inc
|
14.26 | 1.64B | 0 | -150.70M | -125.67M | -1.55 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-07-30 | Iniziato | Raymond James | Strong Buy |
2025-06-30 | Iniziato | H.C. Wainwright | Buy |
2025-04-30 | Iniziato | Guggenheim | Buy |
2025-04-02 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
2025-01-22 | Iniziato | Stifel | Hold |
2024-11-22 | Iniziato | Evercore ISI | Outperform |
2024-03-07 | Iniziato | Piper Sandler | Overweight |
2023-05-01 | Iniziato | Truist | Buy |
2022-08-25 | Downgrade | Goldman | Neutral → Sell |
2022-04-13 | Iniziato | RBC Capital Mkts | Outperform |
2022-01-28 | Iniziato | Goldman | Neutral |
Mostra tutto
Edgewise Therapeutics Inc Borsa (EWTX) Ultime notizie
Will Edgewise Therapeutics Inc. benefit from macro trendsQuarterly Risk Review & Safe Capital Growth Stock Tips - newser.com
Institutional scanner results for Edgewise Therapeutics Inc.2025 Retail Activity & Fast Exit Strategy with Risk Control - newser.com
What does recent volatility data suggest for Edgewise Therapeutics Inc.Market Weekly Review & AI Driven Price Predictions - newser.com
Analyzing recovery setups for Edgewise Therapeutics Inc. investorsJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - newser.com
What indicators show strength in Edgewise Therapeutics Inc.July 2025 WrapUp & Weekly Setup with ROI Potential - newser.com
Predicting Edgewise Therapeutics Inc. trend using moving averages2025 Performance Recap & Weekly High Momentum Picks - newser.com
Aug Mood: Is Edgewise Therapeutics Inc. a cyclical or defensive stockJuly 2025 Macro Moves & Low Risk Growth Stock Ideas - khodrobank.com
Evaluating Edgewise Therapeutics Inc. with trendline analysisEarnings Overview Report & Precise Buy Zone Tips - newser.com
Should you wait for a breakout in Edgewise Therapeutics Inc.July 2025 Recap & Reliable Entry Point Trade Alerts - newser.com
Will earnings trigger a reversal in Edgewise Therapeutics Inc.July 2025 Drop Watch & Consistent Growth Stock Picks - newser.com
Insider Buy: Can Edgewise Therapeutics Inc reach all time highs this yearMarket Growth Summary & Verified Swing Trading Watchlists - khodrobank.com
Risk Report: What analysts say about Edgewise Therapeutics Inc stockBear Alert & Verified Chart Pattern Signals - khodrobank.com
Weekly Trades: Whats the outlook for Edgewise Therapeutics Incs sector2025 Price Action Summary & Real-Time Buy Zone Alerts - khodrobank.com
Full technical analysis of Edgewise Therapeutics Inc. stockRate Cut & Safe Capital Growth Stock Tips - newser.com
Tools to monitor Edgewise Therapeutics Inc. recovery probability2025 Trade Ideas & Verified Short-Term Plans - newser.com
Will Edgewise Therapeutics Inc. continue its uptrendTrade Volume Report & Low Risk Profit Maximizing Plans - newser.com
Wall Street Analysts Think Edgewise Therapeutics (EWTX) Could Surge 182%: Read This Before Placing a Bet - Yahoo Finance
Wall Street Recap: Will Edgewise Therapeutics Inc. benefit from current market trendsWeekly Stock Report & Free Community Supported Trade Ideas - khodrobank.com
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Custom watchlist performance reports with Edgewise Therapeutics Inc.2025 Price Targets & Low Risk Growth Stock Ideas - newser.com
Rhumbline Advisers Increases Holdings in Edgewise Therapeutics, Inc. $EWTX - Defense World
Can technical indicators confirm Edgewise Therapeutics Inc.’s reversalJuly 2025 Momentum & Free High Return Stock Watch Alerts - newser.com
Edgewise Therapeutics, Inc. $EWTX Shares Sold by Amundi - MarketBeat
Analyst Calls: Can Edgewise Therapeutics Inc. generate free cash flowWeekly Profit Report & High Return Trade Opportunity Guides - خودرو بانک
Market Review: Is Edgewise Therapeutics Inc. a strong growth stockJuly 2025 Market Mood & Free Technical Confirmation Trade Alerts - khodrobank.com
Fred Alger Management LLC Acquires Shares of 27,635 Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics, Inc. $EWTX Shares Purchased by Goldman Sachs Group Inc. - MarketBeat
Pattern recognition hints at Edgewise Therapeutics Inc. upside2025 Market Outlook & Daily Profit Maximizing Trade Tips - newser.com
Will Edgewise Therapeutics Inc benefit from current market trendsSwing Trade & Stock Timing and Entry Methods - خودرو بانک
Quarterly Trades: Will Edgewise Therapeutics Inc benefit from current market trendsJuly 2025 Macro Moves & Risk Controlled Swing Alerts - khodrobank.com
Gainers Report: Can Edgewise Therapeutics Inc reach all time highs this year2025 Earnings Surprises & Daily Entry Point Alerts - خودرو بانک
Entry Recap: Is Edgewise Therapeutics Inc subject to activist investor interest2025 Momentum Check & Free Safe Capital Growth Stock Tips - khodrobank.com
Market Outlook: Is Edgewise Therapeutics Inc a cyclical or defensive stockQuarterly Trade Review & Risk Controlled Swing Trade Alerts - خودرو بانک
Woodline Partners LP Purchases 529,591 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics, Inc. $EWTX Shares Acquired by Adage Capital Partners GP L.L.C. - MarketBeat
Parkman Healthcare Partners LLC Acquires 44,234 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Granahan Investment Management LLC Has $4.79 Million Stock Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Eventide Asset Management LLC Acquires Shares of 568,310 Edgewise Therapeutics, Inc. $EWTX - MarketBeat
EFG Asset Management North America Corp. Acquires 63,048 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Cormorant Asset Management LP Buys 695,458 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics Issues Inducement Grants Covering 50,000 Shares to New Employees - geneonline.com
Can Edgewise Therapeutics Inc. be the next market leaderDip Buying & Free Accurate Trade Setup Notifications - beatles.ru
MPM Bioimpact LLC Buys 26,128 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics, Inc. $EWTX Position Raised by First Light Asset Management LLC - MarketBeat
Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Edgewise Therapeutics Inc Azioni (EWTX) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
Russell Alan J | Chief Scientific Officer |
Aug 26 '25 |
Sale |
14.60 |
100,000 |
1,459,760 |
23,400 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):